Reviewed by Michael Gill, B. Sc.
Image of Regional Centre for the Treatment of Eating Disorders in Ottawa, Canada.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Unguided Self-Help, GPIPfor Binge Eating Disorder (BED)

18+
All Sexes
Binge Eating Disorder (BED) affects as many as 3% of women and men in Ontario, 8% of obese individuals, and 30% to 50% of those participating in weight loss programs. BED, the most common eating disorder, is characterized by over-eating with loss of control (i.e., binge eating), but with no purging (e.g., vomiting).Our previous research indicates that the total health care costs for women with BED is 36% higher than the Canadian average for women of a similar age, and that health care costs significantly decreased following intensive treatment at our Centre. The main goal of our study is to inform the development of a stepped care approach to the treatment of BED. Stepped care involves providing easily accessible low intensity treatment first, and then providing more expensive intensive treatment second, if necessary. The second goal is to assess if a second more intensive step of treatment provides added value. Although stepped care for BED is suggested by a number of clinicians and researchers, no study adequately tests predictors of who might benefit from minimal treatment alone and who would require the more intensive second step. The results of this study will guide decision making regarding who benefits from stepped care, and will help to increase the accessibility, availability, and cost effectiveness of psychological treatments for BED.
Waitlist Available
Has No Placebo
Regional Centre for the Treatment of Eating DisordersGeorge A Tasca, Ph.D,C.Psych
24 Binge Eating Clinical Trials Near Me
Top Hospitals for Binge Eating Clinical Trials
Image of Drexel University, Stratton Hall in Pennsylvania.
Drexel University, Stratton Hall
Philadelphia
3Active Trials
5All Time Trials for Binge Eating
2018First Binge Eating Trial
Top Treatments for Binge Eating Clinical Trials
Treatment Name
Active Binge Eating Clinical Trials
All Time Trials for Binge Eating
First Recorded Binge Eating Trial
LDX
2
2
2019
NB medication (Naltrexone Bupropion combination)
2
2
2017
Behavioral Therapy for Eating Disorders
1
2
2020
Cognitive Behavioral Therapy (CBT)
1
4
1994
Cognitive behavioral therapy guided self help (CBTgsh)
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Binge Eating
Treatment
Year
Sponsor
ACT-539313
2021
Idorsia Pharmaceuticals Ltd.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: November 15th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://pubmed.ncbi.nlm.nih.gov/115569412 Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. https://pubmed.ncbi.nlm.nih.gov/114382463 Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6. https://pubmed.ncbi.nlm.nih.gov/40532614 Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. https://pubmed.ncbi.nlm.nih.gov/83299705 Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994 Dec;16(4):363-70. https://pubmed.ncbi.nlm.nih.gov/78664156 Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1;61(3):348-58. Epub 2006 Jul 3. Erratum in: Biol Psychiatry. 2012 Jul 15;72(2):164. https://pubmed.ncbi.nlm.nih.gov/168153227 Forbush KT, Wildes JE, Pollack LO, Dunbar D, Luo J, Patterson K, Petruzzi L, Pollpeter M, Miller H, Stone A, Bright A, Watson D. Development and validation of the Eating Pathology Symptoms Inventory (EPSI). Psychol Assess. 2013 Sep;25(3):859-78. doi: 10.1037/a0032639. Epub 2013 Jul 1. https://pubmed.ncbi.nlm.nih.gov/238151168 Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011 Jul;68(7):724-31. doi: 10.1001/archgenpsychiatry.2011.74. https://pubmed.ncbi.nlm.nih.gov/217272559 Latner JD, Mond JM, Kelly MC, Haynes SN, Hay PJ. The Loss of Control Over Eating Scale: development and psychometric evaluation. Int J Eat Disord. 2014 Sep;47(6):647-59. doi: 10.1002/eat.22296. Epub 2014 May 26. https://pubmed.ncbi.nlm.nih.gov/2486235110 Boutelle KN, Zucker NL, Peterson CB, Rydell SA, Cafri G, Harnack L. Two novel treatments to reduce overeating in overweight children: a randomized controlled trial. J Consult Clin Psychol. 2011 Dec;79(6):759-71. doi: 10.1037/a0025713. https://pubmed.ncbi.nlm.nih.gov/22122291